Phibro Animal Health Affirms 2024 Adj. EPS And Net Sales Guidance
We affirm our previously issued fiscal year 2024 guidance for the following measures:
- Net sales of $980 million to $1.020 billion
- Adjusted EBITDA of $106 million to $112 million
- Adjusted net income of $42 million to $47 million, and
- Adjusted diluted EPS of $1.04 to $1.16